VNS Therapyin Clinics

Medical Use
FDA-approved for epilepsy (since 1997) and treatment-resistant depression (since 2005)

Expanding Applications
Research supports VNS for PTSD, anxiety disorders, migraine relief, and chronic pain.

Adoption in India
Limited clinical use, mainly in neurology and psychiatry. Emerging interest in non-invasive VNS (nVNS) for wellness.

Global Expansion
Widely used in the US, UK, and EU in hospitals, psychiatric centers, and wellness programs.